🇺🇸 FDA
Pipeline program

AVI-5126

AVI-5126-25

Phase 2 small_molecule terminated

Quick answer

AVI-5126 for Cardiovascular Disease is a Phase 2 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Sarepta Therapeutics
Indication
Cardiovascular Disease
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials